Inspire Medical Systems (2DR) Stock Statistics & Valuation Metrics

Inspire Medical Systems has a market cap or net worth of EUR 1.76B. The enterprise value is EUR 999.46M.

Market Cap

EUR 1.76B

Enterprise Value

EUR 999.46M

Inspire Medical Systems has 28,910,376 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding

28,910,376

Owned by Insiders

1.72%

Owned by Institutions

58.86%

Inspire Medical Systems’s return on equity (ROE) is 0.19 and return on invested capital (ROIC) is 6.26%.

Return on Equity (ROE)

0.19

Return on Assets (ROA)

0.16

Return on Invested Capital (ROIC)

6.26%

Return on Capital Employed (ROCE)

0.06

Revenue Per Employee

684.16K

Profits Per Employee

109.09K

Employee Count

1,333

Asset Turnover

1.01

Inventory Turnover

0.92

The current PE Ratio of Inspire Medical Systems is 14.61. Inspire Medical Systems’s PEG ratio is 0.09.

PE Ratio

14.61

PS Ratio

2.19

PB Ratio

2.38

Price to FCF

16.81

Price to Operating Cash Flow

12.50

PEG Ratio

0.09

In the last 12 months, Inspire Medical Systems had revenue of 911.98M and earned 145.42M in profits. Earnings per share was 4.95.

Revenue

911.98M

Gross Profit

778.76M

Operating Income

50.95M

Pretax Income

65.70M

Net Income

145.42M

EBITDA

79.79M

Earnings Per Share (EPS)

4.95

In the last 12 months, operating cash flow was 157.07M and capital expenditures -39.98M, giving a free cash flow of 117.09M billion.

Operating Cash Flow

157.07M

Free Cash Flow

117.09M

Free Cash Flow per Share

4.06

Inspire Medical Systems pays an annual dividend of ―, resulting in a dividend yield of ―

Dividend Per Share

―

Dividend Yield

―

Payout Ratio

N/A

Free Cash Flow Yield

5.95%

Earnings Yield

6.88%

Beta

0.63

52-Week Price Change

-3.79%

50-Day Moving Average

58.43

200-Day Moving Average

48.77

Relative Strength Index (RSI)

53.12

Average Volume (3m)

―

Inspire Medical Systems upcoming earnings date is Nov 02, 2026, After Close (Not Confirmed).

Last Earnings Date

Aug 03, 2026

Next Earnings Date

Nov 02, 2026

Ex-Dividend Date

―

Inspire Medical Systems as a current ratio of 6.08, with Debt / Equity ratio of 4.12%

Current Ratio

6.08

Quick Ratio

4.56

Debt to Market Cap

0.00

Net Debt to EBITDA

-0.91

Interest Coverage Ratio

371.93

In the past 12 months, Inspire Medical Systems has paid -79.72M in taxes.

Income Tax

-79.72M

Effective Tax Rate

-1.21

Inspire Medical Systems EV to EBITDA ratio is 22.51, with an EV/FCF ratio of 15.97.

EV to Sales

2.08

EV to EBITDA

22.51

EV to Free Cash Flow

15.97

EV to Operating Cash Flow

11.91

Inspire Medical Systems has EUR 320.68M in cash and marketable securities with EUR 29.09M in debt, giving a net cash position of EUR 291.59M billion.

Cash & Marketable Securities

EUR 320.68M

Total Debt

EUR 29.09M

Net Cash

EUR 291.59M

Net Cash Per Share

EUR 10.09

Tangible Book Value Per Share

EUR 28.63

Gross margin is 86.13%, with operating margin of 6.02%, and net profit margin of 15.03%.

Gross Margin

86.13%

Operating Margin

6.02%

Pretax Margin

7.72%

Net Profit Margin

15.03%

EBITDA Margin

9.25%

EBIT Margin

7.33%

The average price target for Inspire Medical Systems is EUR 61.70, which is 11.43% higher than the current price. The consensus rating is Neutral

Price Target

EUR 61.70

Price Target Upside

0.33% Upside

Analyst Consensus

Neutral

Analyst Count

15

Revenue Growth Forecast

-2.76%

EPS Growth Forecast

141.27%

Smart Score

3

AI Score

―